Evidence map›Paper›PMID 34060628›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2021

The Autophagy Inducer Spermidine Protects Against Metabolic Dysfunction During Overnutrition.

Chen-Yu Liao, Oona M P Kummert, Amanda M Bair, Nora Alavi, Josef Alavi, Delana M Miller, Isha Bagga, Anja M Schempf, Yueh-Mei Hsu, Bruce D Woods and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Interplay between ALK2Cell death discovery · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 1 institution in 2 countries.

Chen-Yu LiaoBuck Institute for Research on Aging, Novato, California, USA.ORCID 0000-0002-6033-9415
Oona M P KummertBuck Institute for Research on Aging, Novato, California, USA.
Amanda M BairBuck Institute for Research on Aging, Novato, California, USA.
Nora AlaviBuck Institute for Research on Aging, Novato, California, USA.ORCID 0000-0002-6621-8972
Josef AlaviBuck Institute for Research on Aging, Novato, California, USA.
Delana M MillerBuck Institute for Research on Aging, Novato, California, USA.
Isha BaggaBuck Institute for Research on Aging, Novato, California, USA.
Anja M SchempfBuck Institute for Research on Aging, Novato, California, USA.
Yueh-Mei HsuBuck Institute for Research on Aging, Novato, California, USA.
Bruce D WoodsBuck Institute for Research on Aging, Novato, California, USA.
Stephen M Brown MayfieldBuck Institute for Research on Aging, Novato, California, USA.
Angelina N MitchellBuck Institute for Research on Aging, Novato, California, USA.
Gabriella TannadyBuck Institute for Research on Aging, Novato, California, USA.
Aislinn R TalbotBuck Institute for Research on Aging, Novato, California, USA.
Aaron M DueckBuck Institute for Research on Aging, Novato, California, USA.
Ricardo Barrera OvandoBuck Institute for Research on Aging, Novato, California, USA.
Heather D ParkerBuck Institute for Research on Aging, Novato, California, USA.
Junying WangBuck Institute for Research on Aging, Novato, California, USA.
Jane K SchoeneweisBuck Institute for Research on Aging, Novato, California, USA.
Brian K KennedyBuck Institute for Research on Aging, Novato, California, USA.
Buck Institute for Research on Aging · US

Funding

mTORC1 signaling in aging and metabolismR01AG050441 · NIA · BUCK INSTITUTE FOR RESEARCH ON AGING · PI KENNEDY, BRIAN K · 2016 to 2020
$2.8M
NIA NIH HHS R01 AG050441
6 · The paper itself

Abstract

Autophagy, a process catabolizing intracellular components to maintain energy homeostasis, impacts aging and metabolism. Spermidine, a natural polyamine and autophagy activator, extends life span across a variety of species, including mice. In addition to protecting cardiac and liver tissue, spermidine also affects adipose tissue through unexplored mechanisms. Here, we examined spermidine in the links between autophagy and systemic metabolism. Consistently, daily injection of spermidine delivered even at late life is sufficient to cause a trend in life-span extension in wild-type mice. We further found that spermidine has minimal metabolic effects in young and old mice under normal nutrition. However, spermidine counteracts high-fat diet (HFD)-induced obesity by increasing lipolysis in visceral fat. Mechanistically, spermidine increases the hepatokine fibroblast growth factor 21 (FGF21) expression in liver without reducing food intake. Spermidine also modulates FGF21 in adipose tissues, elevating FGF21 expression in subcutaneous fat, but reducing it in visceral fat. Despite this, FGF21 is not required for spermidine action, since Fgf21-/- mice were still protected from HFD. Furthermore, the enhanced lipolysis by spermidine was also independent of autophagy in adipose tissue, given that adipose-specific autophagy-deficient (Beclin-1flox/+Fabp4-cre) mice remained spermidine-responsive under HFD. Our results suggest that the metabolic effects of spermidine occur through systemic changes in metabolism, involving multiple mechanistic pathways.

Indexed as

Fibroblast Growth FactorsSpermidineAdipose TissueAnimalsAutophagyDiet, High-FatLiverMiceMice, Inbred C57BLObesityFibroblast Growth FactorsSpermidineAgingFGF21High-fat dietMetabolismMice

Identifiers

PMID34060628
PMCPMC8436989
OpenAlexW3164799781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.